ArticleInternational journal of hepatology2012
Noninvasive evaluation of portal hypertension: emerging tools and techniques.
Article in International journal of hepatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Artificial Intelligence Enabled Diagnostics Using Photoplethysmography (PPG): Beyond SpOLife (Basel, Switzerland) · 2026Review
- Metabolomics reveals altered metabolites in cirrhotic patients with severe portal hypertension in Tibetan population.Frontiers in medicine · 2024Article
- Usefulness of virtual touch tissue quantification for predicting the presence of esophageal varices in patients with liver cirrhosis.JGH open : an open access journal of gastroenterology and hepatology · 2021Article
- Ultrasound-based liver elastography: current results and future perspectives.Abdominal radiology (New York) · 2020Review
- Endogenous motion of liver correlates to the severity of portal hypertension.World journal of gastroenterology · 2020Article
- Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.World journal of gastroenterology · 2019Article
- Noninvasive Evaluation of Portal Hypertension Using a Supervised Learning Technique.Journal of healthcare engineering · 2017Article
- Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography.International journal of hepatology · 2015Review
- Portal hypertension as immune mediate disease.Hepatitis monthly · 2014Review
- Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.Alimentary pharmacology & therapeutics · 2013Article
- Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study.International journal of cardiology · 2013Article
- Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension.World journal of gastroenterology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Portal hypertension is the main cause of complications in patients with cirrhosis. However, evaluating the development and progression of portal hypertension represents a challenge for clinicians. There has been considerable focus on the potential role of noninvasive markers of portal hypertension that could be used to stratify patients with respect to the stage of portal hypertension and to monitor disease progression or treatment response in a longitudinal manner without having to undertake repeated invasive assessment. The pathogenesis of portal hypertension is increasingly understood and emerging knowledge of the vascular processes that underpin portal hypertension has paved the way for exploring novel biomarkers of vascular injury, angiogenesis, and endothelial dysfunction. In this paper we focus on the pathogenesis of portal hypertension and potential non-invasive biomarkers with particular emphasis on serum analytes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.